Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.14
Data as of Jan 23
 -0.04 / -0.65%
Today’s Change
3.10
Today|||52-Week Range
7.84
-18.78%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Broadfin Capital Llc
Buy7/17/2014436,884$4.48$2.0M+36.44%
Broadfin Capital Llc
Buy7/16/2014411,693$4.48$1.8M+36.44%
Broadfin Capital Llc
Buy7/21/2014388,659$4.73$1.8M+24.54%
Broadfin Capital Llc
Buy7/18/2014388,200$4.73$1.8M+28.18%
Israel Robert J
Sale11/13/201410,000$6.83$68.3K-4.81%
Israel Robert J
Sale11/21/20149,000$7.00$63.0K-9.31%
Israel Robert J
Buy11/13/201410,000$5.33$53.3K-4.81%
Israel Robert J
Buy11/21/20149,000$5.35$48.2K-9.31%
Israel Robert J
Sale11/11/20145,000$6.53$32.7K-2.23%
Israel Robert J
Buy11/11/20145,000$5.03$25.2K-2.23%
Page of 2

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.